The physicochemical/thermodynamic balance of advanced drug liposomal delivery systems
- 230 Downloads
The aim of this work is to study the morphological characteristics via fractal analysis and the alterations of the thermotropic behavior of dipalmitoylphosphatidylcholine (DPPC) liposomes, caused by the incorporation of cholesterol, poly(amidoamine) (PAMAM) dendrimer, and MPOx (poly(2-methyl-2-oxazoline)-grad-poly(2-phenyl-2-oxazoline)) gradient block copolymer (9:1 molar ratio). A gamut of light scattering techniques and differential scanning calorimetry were used in order to extract information on the morphological (in different dispersion media) and thermodynamic characteristics of liposomal drug nanocarriers, respectively. The vesicles’ structure of liposomes has a different thermodynamic content, which corresponds to a different thermotropic behavior, in comparison to pure lipid bilayers. The observed metastable phase only for DPPC liposomes has been considered as a “physical impurity”, which leads to “physical incompatibility” and consequently promotes the aggregation of DPPC liposomes in aqueous media. The incorporation of biomaterials such as PAMAM G4 and MPOx, caused alterations in the thermotropic behavior of DPPC liposomes affecting only the main transition specific enthalpy ΔH. All the other calorimetric parameters remained unaltered. These findings supported the hypothesis that the exceptional stability and transition cooperativity of the chimeric liposomal membrane might be due to the reduction of the vesicle size with the smaller membrane curvature that is indicated by the fractal dimensionality of the system. In conclusion, the results from the thermal analysis of the liposomal systems were in line with the picture of their structural characteristics, as indicated by the interplay between physicochemical and thermodynamical parameters, which determines their fractal morphology.
KeywordsChimeric liposomes Fractal dimension Colloidal stability DSC Drug delivery systems
The authors would like to thank prof. Dimitrios Fessas for his valuable comments and discussions.
- 5.Gardikis K, Hatziantoniou S, Bucos M, Fessas D, Signorelli M, Felekis T, Zervou M, Screttas C, Steele B, Ionov M, Scretta M, Klajnert B, Bryszewska M, Demetzos C. New drug delivery nanosystem combining liposomal and dendrimeric technology (liposomal locked-in dendrimers) for cancer therapy. J Pharm Sci. 2010;99:3561–71.CrossRefGoogle Scholar
- 6.Gardikis K, Fessas D, Signorelli M, Dimas K, Tsimplouli C, Ionov M, Demetzos C. A new chimeric drug delivery nano system (Chi-aDDnS) composed of PAMAM G 3.5 dendrimer and liposomes as doxorubicin’s carrier. In vitro pharmacological studies. J Nanosci Nanotechnol. 2011;5:3764–72.CrossRefGoogle Scholar